A 62-year-old male with underlying COPD develops a viral upper respiratory infection and begins taking an over-the-counter decongestant. Sholy thereafter he experiences palpitations and presents to the emergency room, where the given rhythm strip is obtained, demonstrating:
**Core Concept**
The question assesses the patient's risk of developing a life-threatening arrhythmia due to the interaction between a decongestant and his underlying condition, COPD. The key concept is the concept of **sympathetic overdrive** and its potential to precipitate **ventricular arrhythmias**.
**Why the Correct Answer is Right**
The patient's COPD is a condition characterized by **chronic bronchitis and emphysema**, leading to **hypoxia** and **hypercapnia**. The viral upper respiratory infection further exacerbates these conditions, causing **sympathetic overdrive**. The decongestant, which contains **pseudoephedrine**, is a **sympathomimetic agent** that acts on **alpha-adrenergic receptors** to cause vasoconstriction. However, in a patient with COPD, this can lead to **increased sympathetic tone**, which in turn can precipitate **ventricular arrhythmias** such as **torsades de pointes**. The given rhythm strip likely demonstrates this arrhythmia.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not address the underlying mechanism of the patient's arrhythmia. While **sinus tachycardia** can be a response to stress or anxiety, it does not explain the patient's development of a life-threatening arrhythmia.
**Option B:** This option is incorrect because **atrial fibrillation** is not a direct consequence of the patient's use of a decongestant. While the patient's underlying COPD may increase his risk of developing atrial fibrillation, the given rhythm strip likely demonstrates a ventricular arrhythmia.
**Option C:** This option is incorrect because **wide QRS complex tachycardia** is not the most likely diagnosis in this patient. While the patient's use of a decongestant may have contributed to his arrhythmia, the given rhythm strip likely demonstrates a more specific type of ventricular arrhythmia.
**Option D:** This option is incorrect because **sinus bradycardia** is not consistent with the patient's presentation of palpitations. The patient's use of a decongestant would be more likely to cause an increase in heart rate, rather than a decrease.
**Clinical Pearl / High-Yield Fact**
When treating patients with COPD, it is essential to be aware of the potential for **sympathetic overdrive** to precipitate life-threatening arrhythmias. Avoiding the use of sympathomimetic agents, such as decongestants, can help mitigate this risk.
**Correct Answer:** C.